GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (NAS:STAA) » Definitions » Cyclically Adjusted PS Ratio

Staar Surgical Co (Staar Surgical Co) Cyclically Adjusted PS Ratio : 9.38 (As of Jun. 07, 2024)


View and export this data going back to 1983. Start your Free Trial

What is Staar Surgical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-07), Staar Surgical Co's current share price is $38.66. Staar Surgical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $4.12. Staar Surgical Co's Cyclically Adjusted PS Ratio for today is 9.38.

The historical rank and industry rank for Staar Surgical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

STAA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.58   Med: 10.75   Max: 59.92
Current: 9.83

During the past years, Staar Surgical Co's highest Cyclically Adjusted PS Ratio was 59.92. The lowest was 2.58. And the median was 10.75.

STAA's Cyclically Adjusted PS Ratio is ranked worse than
87.18% of 476 companies
in the Medical Devices & Instruments industry
Industry Median: 2.16 vs STAA: 9.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Staar Surgical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was $1.582. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $4.12 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Staar Surgical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Staar Surgical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Cyclically Adjusted PS Ratio Chart

Staar Surgical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.57 32.34 31.61 14.14 7.89

Staar Surgical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.88 14.06 10.36 7.89 9.30

Competitive Comparison of Staar Surgical Co's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Cyclically Adjusted PS Ratio falls into.



Staar Surgical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Staar Surgical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=38.66/4.12
=9.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Staar Surgical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.582/131.7762*131.7762
=1.582

Current CPI (Mar. 2024) = 131.7762.

Staar Surgical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.525 100.560 0.688
201409 0.474 100.428 0.622
201412 0.436 99.070 0.580
201503 0.490 99.621 0.648
201506 0.478 100.684 0.626
201509 0.472 100.392 0.620
201512 0.537 99.792 0.709
201603 0.482 100.470 0.632
201606 0.522 101.688 0.676
201609 0.495 101.861 0.640
201612 0.545 101.863 0.705
201703 0.499 102.862 0.639
201706 0.536 103.349 0.683
201709 0.558 104.136 0.706
201712 0.603 104.011 0.764
201803 0.629 105.290 0.787
201806 0.771 106.317 0.956
201809 0.690 106.507 0.854
201812 0.661 105.998 0.822
201903 0.695 107.251 0.854
201906 0.849 108.070 1.035
201909 0.833 108.329 1.013
201912 0.827 108.420 1.005
202003 0.783 108.902 0.947
202006 0.776 108.767 0.940
202009 0.977 109.815 1.172
202012 0.938 109.897 1.125
202103 1.031 111.754 1.216
202106 1.260 114.631 1.448
202109 1.177 115.734 1.340
202112 1.192 117.630 1.335
202203 1.282 121.301 1.393
202206 1.648 125.017 1.737
202209 1.535 125.227 1.615
202212 1.296 125.222 1.364
202303 1.485 127.348 1.537
202306 1.864 128.729 1.908
202309 1.627 129.860 1.651
202312 1.549 129.419 1.577
202403 1.582 131.776 1.582

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Staar Surgical Co  (NAS:STAA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Staar Surgical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Staar Surgical Co (Staar Surgical Co) Business Description

Traded in Other Exchanges
Address
25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.
Executives
Broadwood Partners Lp 10 percent owner BROADWOOD CAPITAL INC., 142 WEST 57TH STREET, 11TH FLOOR, NEW YORK NY 10019
Elizabeth Yeu Lin director 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
Aimee S Weisner director ONE EDWARDS WAY, IRVINE CA 92614
Warren Foust officer: Chief Operating Officer 17 MAGNOLIA DRIVE, LADERA RANCH CA 92694
Magda Michna officer: Chief Clinical, Regulatory, C/O PRESBIA, 8845 IRVINE CENTER DRIVE, SUITE 100, IRVINE CA 92618
Keith Holliday officer: V.P., Research & Development 1911 WALKER AVENUE, MONROVIA CA 91016
Robert Studholme officer: Senior VP, Operations 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
James E Francese officer: VP, Global Marketing 1911 WALKER AVE, MONROVIA CA 91016
Caren L Mason director 2523 PARK RIDGE DRIVE, ESCONDIDO CA 92025
Samuel J Gesten officer: VP, General Counsel 1911 WALKER AVENUE, MONROVIA CA 91016
Patrick F. Williams officer: Chief Financial Officer C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Hans-martin Blickensdoerfer officer: VP, International Marketing 1911 WALKER AVENUE, MONROVIA CA 91016
Lou Silverman director
Graydon C. Hansen officer: Sr. VP, Global Operations 25651 ATLANTIC OCEAN DRIVE, LAKE FORST CA 92630
Jon K. Hayashida officer: VP, Global Clinical, Medical 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630